Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) (2013 - 2026)

Ultragenyx Pharmaceutical (RARE) Property, Plant & Equipment (Net) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 64,489.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 116.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 8,690.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.61 Bn
9 Abivax 91.96 Bn 91.96 Bn - 2.09 Mn
10 Ultragenyx Pharmaceutical 2.77 Bn 2.36 Bn 106.00 Mn 239.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 239.00 Mn
Mar 31, 2026 239.00 Mn
Dec 31, 2025 244.00 Mn
Dec 31, 2025 244.00 Mn
Sep 30, 2025 249.96 Mn
Sep 30, 2025 249.96 Mn
Jun 30, 2025 255.76 Mn
Jun 30, 2025 255.76 Mn
Mar 31, 2025 260.91 Mn
Mar 31, 2025 260.91 Mn
Dec 31, 2024 266.00 Mn
Dec 31, 2024 266.00 Mn
Sep 30, 2024 272.45 Mn
Sep 30, 2024 272.45 Mn
Jun 30, 2024 278.71 Mn
Jun 30, 2024 278.71 Mn
Mar 31, 2024 285.11 Mn
Mar 31, 2024 285.11 Mn
Dec 31, 2023 290.57 Mn
Dec 31, 2023 290.57 Mn